ロード中...
Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes
BACKGROUND: Overweight or obesity contributes to the development of type 2 diabetes mellitus (T2DM) and increases cardiovascular risk. Exenatide, a glucagon-like peptide-1 receptor agonist, significantly reduces glycated hemoglobin (A1C) and body weight and improves cardiovascular risk markers in pa...
保存先:
| 出版年: | Cardiovasc Diabetol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324846/ https://ncbi.nlm.nih.gov/pubmed/25645567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-014-0171-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|